These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11356842)

  • 1. Identification of a motif in the carboxyl terminus of beta -arrestin2 responsible for activation of JNK3.
    Miller WE; McDonald PH; Cai SF; Field ME; Davis RJ; Lefkowitz RJ
    J Biol Chem; 2001 Jul; 276(30):27770-7. PubMed ID: 11356842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3.
    McDonald PH; Chow CW; Miller WE; Laporte SA; Field ME; Lin FT; Davis RJ; Lefkowitz RJ
    Science; 2000 Nov; 290(5496):1574-7. PubMed ID: 11090355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus.
    Guo C; Whitmarsh AJ
    J Biol Chem; 2008 Jun; 283(23):15903-11. PubMed ID: 18408005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates.
    Ho DT; Bardwell AJ; Abdollahi M; Bardwell L
    J Biol Chem; 2003 Aug; 278(35):32662-72. PubMed ID: 12788955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR.
    Miller WE; Houtz DA; Nelson CD; Kolattukudy PE; Lefkowitz RJ
    J Biol Chem; 2003 Jun; 278(24):21663-71. PubMed ID: 12668664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
    Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
    Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus.
    Wang P; Wu Y; Ge X; Ma L; Pei G
    J Biol Chem; 2003 Mar; 278(13):11648-53. PubMed ID: 12538596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway.
    Pan J; Li H; Zhang B; Xiong R; Zhang Y; Kang WY; Chen W; Zhao ZB; Chen SD
    PLoS One; 2015; 10(4):e0119204. PubMed ID: 25856433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
    Seo J; Tsakem EL; Breitman M; Gurevich VV
    J Biol Chem; 2011 Aug; 286(32):27894-901. PubMed ID: 21715332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-arrestin2 enhances beta2-adrenergic receptor-mediated nuclear translocation of ERK.
    Kobayashi H; Narita Y; Nishida M; Kurose H
    Cell Signal; 2005 Oct; 17(10):1248-53. PubMed ID: 16038799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Dvl-1/β-arrestin2/JNK3 interaction disrupts Wnt5a-JNK3 signaling and protects hippocampal CA1 neurons during cerebral ischemia reperfusion.
    Wei X; Gong J; Ma J; Zhang T; Li Y; Lan T; Guo P; Qi S
    Neuropharmacology; 2018 Jun; 135():11-21. PubMed ID: 29510185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does arrestin assemble MAPKs into a signaling complex?
    Song X; Coffa S; Fu H; Gurevich VV
    J Biol Chem; 2009 Jan; 284(1):685-695. PubMed ID: 19001375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2.
    Scott MG; Le Rouzic E; Périanin A; Pierotti V; Enslen H; Benichou S; Marullo S; Benmerah A
    J Biol Chem; 2002 Oct; 277(40):37693-701. PubMed ID: 12167659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Jun N-terminal kinase-3 (JNK3)/stress-activated protein kinase-beta (SAPKbeta) binds and phosphorylates the neuronal microtubule regulator SCG10.
    Neidhart S; Antonsson B; Gilliéron C; Vilbois F; Grenningloh G; Arkinstall S
    FEBS Lett; 2001 Nov; 508(2):259-64. PubMed ID: 11718727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterologous phosphorylation-induced formation of a stability lock permits regulation of inactive receptors by β-arrestins.
    Tóth AD; Prokop S; Gyombolai P; Várnai P; Balla A; Gurevich VV; Hunyady L; Turu G
    J Biol Chem; 2018 Jan; 293(3):876-892. PubMed ID: 29146594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal tyrosine modulation of the endocytic adaptor function of the beta-arrestins.
    Marion S; Fralish GB; Laporte S; Caron MG; Barak LS
    J Biol Chem; 2007 Jun; 282(26):18937-44. PubMed ID: 17456469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
    Willoughby EA; Collins MK
    J Biol Chem; 2005 Jul; 280(27):25651-8. PubMed ID: 15888437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis.
    Miller WE; Maudsley S; Ahn S; Khan KD; Luttrell LM; Lefkowitz RJ
    J Biol Chem; 2000 Apr; 275(15):11312-9. PubMed ID: 10753943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
    Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
    J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.
    Lisnock J; Griffin P; Calaycay J; Frantz B; Parsons J; O'Keefe SJ; LoGrasso P
    Biochemistry; 2000 Mar; 39(11):3141-8. PubMed ID: 10715136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.